Cytosorbents (NASDAQ: CTSO) reported Q3 EPS of ($0.25), $0.15 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $1.26 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.